Clinical Trials Browser

Burkitt Lymphoma

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Rhabdomyosarcoma, Rhabdomyosarcoma, Alveolar, Rhabdomyosarcoma, Embryonal

Burkitt Lymphoma, Down Syndrome, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma

Breast Neoplasms

Prostatic Neoplasms

Prostatic Neoplasms

Prostatic Neoplasms

Breast Carcinoma In Situ, Breast Neoplasms, Triple Negative Breast Neoplasms

Adenocarcinoma Of Esophagus, Parkinson Disease 4, Autosomal Dominant Lewy Body, Esophageal Squamous Cell Carcinoma

Prostatic Neoplasms

Carcinoma, Hepatocellular

Oropharyngeal Neoplasms

Breast Neoplasms

Adenocarcinoma Of Esophagus

Rhabdomyosarcoma, Rhabdomyosarcoma, Alveolar, Rhabdomyosarcoma, Embryonal

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

Burkitt Lymphoma

Urinary Bladder Neoplasms

Hodgkin Disease

Prostatic Neoplasms

Prostate Adenocarcinoma

Uterine Cervical Neoplasms, Vaginal Neoplasms

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Carcinoma, Non-Small-Cell Lung

Breast Neoplasms, Carcinoma, Ductal, Breast, Carcinoma, Lobular

Astrocytoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms

Squamous Cell Carcinoma of Head and Neck, Laryngeal Diseases

Hodgkin Disease, Lymphoma

Hodgkin Disease, Lymphoma

Hodgkin Disease, Lymphoma

Breast Neoplasms

Medulloblastoma

Beckwith-Wiedemann Syndrome, Wilms Tumor

Squamous Cell Carcinoma of Head and Neck

Radiation Therapy

Prostatic Neoplasms

Prostatic Neoplasms

Uterine Cervical Neoplasms

Neoplasms, Prostatic Neoplasms

Fibromatosis, Plantar, Pain

Astrocytoma, Oligodendroglioma, Central Nervous System Neoplasms

Clinical Trials

Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia

Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma

Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma

A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia

TAILORx

PEGASUS

Conventional or Hypofractionated Radiation Therapy in Treating Patients With Prostate Cancer

RADVAN

Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer

KEYNOTE 975

PRIMORDIUM

Radiation Therapy With Protons or Photons in Treating Patients With Liver Cancer

CompARE

PRART

Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the Body

A Study to Compare Early Use of Vinorelbine and Maintenance Therapy for Patients With High Risk Rhabdomyosarcoma

Combining Radiation Therapy With Immunotherapy for the Treatment of Metastatic Squamous Cell Carcinoma of the Head and Neck

Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations

Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer

Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma

Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial

Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial

Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers

Nivolumab and Ipilimumab With or Without Local Consolidation Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer

NIRVANA-LUNG

Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer

Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma

SALTORL

RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease

Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma

Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma

KEYNOTE-756

Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNET

Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor

SANTAL

SENECA

ADOPT

PCS IV

INTERLACE

PEACE1

LedRad

CATNON